|
|
||||||||
Division of Nuclear Medicine of the Department of Radiology and The Clinical Investigation Unit of the Medical Service, Massachusetts General Hospital
Department of Radiology and Medicine, Harvard Medical School, Boston, Massachusetts
R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania
Correspondence: For correspondence and reprints contact: Dr. Alan J. Fischman, Div. of Nuclear Medicine, Massachusetts General Hospital, Boston, MA 02114.
ABSTRACT
Biodistribution and infection imaging properties of 111In-DTPA-IgG, 99mTc-hydrazino nicotinamide-IgG and 111In-WBC were compared in rabbits with E. coli infection. Groups of six rabbits were injected with 10 mCi of 99mTc-IgG plus 0.5 mCi of 111In-IgG or 1 mCi of 99mTc-IgG plus 0.05 mCi of 111In-WBC. At 45 and 1820 hr, dual photon scintigrams were acquired. At both times, the distributions of 99mTc and 111In-IgG were nearly identical. The sites of infection were well visualized with all three radiopharmaceuticals. In the early images, the target-to-background ratios (T/B) for 111In and 99mTc-IgG determined by ROI analysis were 1.95 ± 0.26 and 2.57 ± 0.38 (p = NS). In the delayed images, the T/B ratios increased (p < 0.01) to 3.56 ± 0.49 and 4.90 ± 0.98. At both times, the T/B ratios for 111In-WBC were higher (p < 0.01); 4.17 ± 0.78 at 45 hr and 8.52 ± 1.52 at 1820 hr. These results indicate that all three agents yield excellent images of infection sites. Although 111In-WBC had higher T/B ratios, the ease of preparation of the radiolabeled proteins makes them attractive alternatives for infection imaging.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |